Good News :
1. Max venture profit rise 81.3%
2. Raymond profit rise 356%
3. VIP profit rise from -Rs4 to Rs12 crore
4. Gsk pharma profit rise 8.8%
5. IRB infra toll collection increase from Rs200 to Rs327 crore
Cement, Chemical, Pharma and Textile stocks will go up today
#SANOFI & #GSKCONS : Sanofi and GSK receive approval for their Phase-3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine candidate.(Possitive )
Government has to step up spending before it's too late, says HUL Chairman Sanjiv Mehta
"Growth and controlling inflation have to move in tandem," he said. "There is a risk of inflation, but the bigger risk is the economy going into a tailspin. So there should be an aggressiveness with which we reduce the interest rates, clearly with the risk that there could be more inflation coming."
Johnson & Johnson to begin human trials of COVID-19 vaccine in the second half of July
J&J's study will test the vaccine against a placebo and assess the shot's safety and immune response in 1,045 healthy people aged 18 to 55 years, as well as those 65 years and older. The trial will take place in the United States and Belgium.
GlaxoSmithKline Consumer Healthcare (Q2, YoY) Revenue rose 5.7 percent to Rs 1,345.1 crore. Net profit rose 25.3 percent to Rs 345.3 crore. Ebitda rose 11.9 percent to Rs 395.8 crore. Margin stood at 29.4 percent versus 27.8 percent.